Effect of TEAS on Rocuronium Injection Pain

Injection Pain Clinical Trial

Official title:

Efficacy of TEAS On Prevention of Rocuronium Injection Pain

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04943367
• Other study ID #: Rocuronium injection pain
• Status: Completed
• Phase: N/A
• Start date: July 12, 2021
• Est. completion date: January 5, 2022

Study information

• Verified date: January 2022
• Source: Konya Meram State Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Pain from the injection of rocuronium is a common side effect during anesthetic practice, occurring in 50%-80% of patients. Several methods have been used to reduce this pain. This prospective, randomized study was designed to determine the efficacy of transcutaneous electrical acupuncture point stimulation in reducing the rocuronium injection pain.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: January 5, 2022
• Est. primary completion date: January 5, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 18-65 year aged

• ASA I-III

• Who was to undergo various elective operations.

Exclusion Criteria:

• Cardiovascular surgery

• Patients with pacemakers

• Patients requiring rapid sequential induction

Related Conditions & MeSH terms

• Injection Pain

Intervention

Device:
• TEAS
Transcutaneous electrical acupuncture stimulation

Locations

Country	Name	City	State
Turkey	Betul Kozanhan	Konya

Sponsors (1)

Lead Sponsor	Collaborator
Konya Meram State Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain with rocuronium injection	pain will be graded as no pain; mild pain; moderate pain; severe pain following administration of a priming dose of rocuronium	5 minutes